Related references
Note: Only part of the references are listed.RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NFκB Activation and Lymphoma Survival
Laiqun Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The Gβ5 protein regulates sensitivity to TRAIL-induced cell death in colon carcinoma
D. Fuchs et al.
ONCOGENE (2015)
Control of Life-or-Death Decisions by RIP1 Kinase
Dana E. Christofferson et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 76 (2014)
Cathepsins Limit Macrophage Necroptosis through Cleavage of Rip1 Kinase
Scott McComb et al.
JOURNAL OF IMMUNOLOGY (2014)
Necroptosis in health and diseases
Wen Zhou et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Necroptosis, in vivo detection in experimental disease models
Sandrine Jouan-Lanhouet et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Therapeutic exploitation of necroptosis for cancer therapy
Simone Fulda
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer
Tomer Cooks et al.
CANCER CELL (2013)
Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
Emanuela Grassilli et al.
CLINICAL CANCER RESEARCH (2013)
Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL
William J. Kaiser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Determination of apoptotic and necrotic cell death in vitro and in vivo
Tom Vanden Berghe et al.
METHODS (2013)
Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis
L. Steinhart et al.
CELL DEATH & DISEASE (2013)
Targeted therapies in colorectal cancer—an integrative view by PPPM
Suzanne Hagan et al.
EPMA Journal (2013)
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Liming Sun et al.
CELL (2012)
IAPs: Guardians of RIPK1
M. Darding et al.
CELL DEATH AND DIFFERENTIATION (2012)
Notch1 signaling promotes survival of glioblastoma cells via EGFR-mediated induction of anti-apoptotic Mcl-1
A. Fassl et al.
ONCOGENE (2012)
Staurosporine Induces Necroptotic Cell Death under Caspase-Compromised Conditions in U937 Cells
Zsuzsanna A. Dunai et al.
PLOS ONE (2012)
A novel role for RIP1 kinase in mediating TNFα production
D. E. Christofferson et al.
CELL DEATH & DISEASE (2012)
Killing a cancer: what are the alternatives?
Peter Kreuzaler et al.
NATURE REVIEWS CANCER (2012)
NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-α Feedforward Signaling
Sharon Biton et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Regulation of NF-kappa B signaling by caspases and MALT1 paracaspase
Jens Staal et al.
CELL RESEARCH (2011)
cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms
Maria Feoktistova et al.
MOLECULAR CELL (2011)
The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs
Tencho Tenev et al.
MOLECULAR CELL (2011)
Smac Mimetic Bypasses Apoptosis Resistance in FADD- or Caspase-8-Deficient Cells by Priming for Tumor Necrosis Factor α-Induced Necroptosis
Bram Laukens et al.
NEOPLASIA (2011)
Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner
B. L. Probst et al.
CELL DEATH AND DIFFERENTIATION (2010)
Molecular mechanisms of necroptosis: an ordered cellular explosion
Peter Vandenabeele et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
Sudan He et al.
CELL (2009)
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
G. Kroemer et al.
CELL DEATH AND DIFFERENTIATION (2009)
Radiosensitization of solid tumors by Z-VAD, a pan-caspase inhibitor
Luigi Moretti et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death Pathway
Junichi Hitomi et al.
CELL (2008)
Identification of RIP1 kinase as a specific cellular target of necrostatins
Alexei Degterev et al.
NATURE CHEMICAL BIOLOGY (2008)
IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis
Eugene Varfolomeev et al.
CELL (2007)
Shikonin circumvents cancer drug resistance by induction of a necroptotic death
Weidong Han et al.
MOLECULAR CANCER THERAPEUTICS (2007)
RIP1, a kinase on the crossroads of a cell's decision to live or die
N. Festjens et al.
CELL DEATH AND DIFFERENTIATION (2007)
Caspases leave the beaten track:: caspase-mediated activation of NF-κB
M Lamkanfi et al.
JOURNAL OF CELL BIOLOGY (2006)
First-in-class pan caspase inhibitor developed for the treatment of liver disease
SD Linton et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Mechanistic and predictive profiling of 5-fluorouracil resistance in human cancer cells
WG Wang et al.
CANCER RESEARCH (2004)
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
O Micheau et al.
CELL (2003)
Caspase-8 and caspase-10 activate NF-κB through RIP, NIK and IKKα kinases
Y Shikama et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapy
JY Douillard et al.
ANNALS OF ONCOLOGY (2003)
Activation of the NF-κB pathway by Caspase 8 and its homologs
PM Chaudhary et al.
ONCOGENE (2000)